Contribution of Breast Cancer to Overall Mortality for US Women
- PMID: 29554467
- PMCID: PMC5963706
- DOI: 10.1177/0272989X17717981
Contribution of Breast Cancer to Overall Mortality for US Women
Abstract
Objective: Breast cancer simulation models must take changing mortality rates into account to evaluate the potential impact of cancer control interventions. We estimated mortality rates due to breast cancer and all other causes combined to determine their impact on overall mortality by year, age, and birth cohort.
Methods: Based on mortality rates from publicly available datasets, an age-period-cohort model was used to estimate the proportion of deaths due to breast cancer for US women aged 0 to 119 years, with birth years 1900 to 2000. Breast cancer mortality was calculated as all-cause mortality multiplied by the proportion of deaths due to breast cancer; other-cause mortality was the difference between all-cause and breast cancer mortality.
Results: Breast cancer and other-cause mortality rates were higher for older ages and birth cohorts. The percent of deaths due to breast cancer increased across birth cohorts from 1900 to 1940 then decreased. Among 50-year-old women, in the 1920 birth cohort, 52 (9.9%) of 100,000 deaths (95% CI, 9.8% to 10.1%) were attributed to breast cancer whereas 476 of 100,000 were due to other causes; in the 1960 birth cohort, 22 (8.5%) of 100,000 deaths (95% CI, 8.3% to 8.7%) were attributed to breast cancer with 242 of 100,000 deaths due to other causes. The percentage of all deaths due to breast cancer was highest (4.1% to 12.9%) for women in their 40s and 50s for all birth cohorts.
Conclusions: This study offers evidence that advances in breast cancer screening and treatment have reduced breast cancer mortality for women across the age spectrum, and provides estimates of age-, year- and birth cohort-specific competing mortality rates for simulation models. Other-cause mortality estimates are important in these models because most women die from causes other than breast cancer.
Keywords: age-period-cohort modeling; breast cancer; mortality; simulation modeling.
Conflict of interest statement
Figures



Similar articles
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
Competing risks to breast cancer mortality.J Natl Cancer Inst Monogr. 2006;(36):15-9. doi: 10.1093/jncimonographs/lgj004. J Natl Cancer Inst Monogr. 2006. PMID: 17032889
-
How does breast cancer mortality compare with that of other cancers and selected cardiovascular diseases at different ages in U.S. women?J Womens Health Gend Based Med. 2000 Nov;9(9):999-1006. doi: 10.1089/15246090050200033. J Womens Health Gend Based Med. 2000. PMID: 11103100
-
The lifetime risk of developing breast cancer.J Natl Cancer Inst. 1993 Jun 2;85(11):892-7. doi: 10.1093/jnci/85.11.892. J Natl Cancer Inst. 1993. PMID: 8492317
-
New Trend in Old-Age Mortality: Gompertzialization of Mortality Trajectory.Gerontology. 2019;65(5):451-457. doi: 10.1159/000500141. Epub 2019 May 20. Gerontology. 2019. PMID: 31295741 Free PMC article. Review.
Cited by
-
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.JAMA. 2018 Jan 9;319(2):154-164. doi: 10.1001/jama.2017.19130. JAMA. 2018. PMID: 29318276 Free PMC article.
-
Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.Ann Intern Med. 2020 Sep 1;173(5):331-341. doi: 10.7326/M19-3481. Epub 2020 Jul 7. Ann Intern Med. 2020. PMID: 32628531 Free PMC article.
-
Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study.BMJ. 2025 Jul 8;390:e083542. doi: 10.1136/bmj-2024-083542. BMJ. 2025. PMID: 40628457 Free PMC article.
-
Cost Effectiveness of Gene Expression Profile Testing in Community Practice.J Clin Oncol. 2018 Feb 20;36(6):554-562. doi: 10.1200/JCO.2017.74.5034. Epub 2018 Jan 8. J Clin Oncol. 2018. PMID: 29309250 Free PMC article.
-
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.J Natl Cancer Inst. 2021 Aug 2;113(8):1017-1026. doi: 10.1093/jnci/djaa218. J Natl Cancer Inst. 2021. PMID: 33515225 Free PMC article.
References
-
- Centers for Disease Control and Prevention, U.S. Department of Health & Human Services. [Accessed December 1, 2016];WONDER Online Databases, Underlying Cause of Death. Accessed at http://wonder.cdc.gov.
-
- DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42. - PubMed
-
- Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2013. National Cancer Institute; Bethesda, MD: Apr, 2016. http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site.
-
- Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW. The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections. CA Cancer J Clin. 2016;66(5):359–69. - PubMed
-
- Yasmeen F, Hyndman RJ, Erbas B. Forecasting age-related changes in breast cancer mortality among white and black US women: a functional data approach. Cancer epidemiology. 2010;34(5):542–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical